Home/Ellipses Pharma/Professor Sir Christopher Evans OBE
PS

Professor Sir Christopher Evans OBE

Executive Chairman & Founder

Ellipses Pharma

Therapeutic Areas

Ellipses Pharma Pipeline

DrugIndicationPhase
EP0031/A400RET-altered cancersNDA Submitted
B7H3 Antibody-Drug ConjugateNot specified (oncology)Clinical